Publication
Fidaxomicin for Clostridiodes difficile infection in inflammatory bowel disease: a multicenter retrospective cohort study
dc.contributor.author | Noviello, D. | |
dc.contributor.author | Chaparro, M. | |
dc.contributor.author | Viganò, C. | |
dc.contributor.author | Blesl, A. | |
dc.contributor.author | Barberio, B. | |
dc.contributor.author | Yanai, H. | |
dc.contributor.author | Macaluso, F. | |
dc.contributor.author | Iglesias, R. Ferreiro | |
dc.contributor.author | Bezzio, C. | |
dc.contributor.author | Zilli, A. | |
dc.contributor.author | Molnár, T. | |
dc.contributor.author | Gheorghe, C. | |
dc.contributor.author | Conforti, F. S. | |
dc.contributor.author | Innocenti, T. | |
dc.contributor.author | Saibeni, S. | |
dc.contributor.author | Bossuyt, P. | |
dc.contributor.author | Oliveira, R. F. de | |
dc.contributor.author | Gabrielli, A. M. Carvalhas | |
dc.contributor.author | Losco, A. | |
dc.contributor.author | Vieujean, S. | |
dc.contributor.author | Tettoni, E. | |
dc.contributor.author | Pirola, L. | |
dc.contributor.author | Calderone, S. | |
dc.contributor.author | Cohen, M. Kornowski | |
dc.contributor.author | Dragoni, G. | |
dc.contributor.author | Rath, T. | |
dc.contributor.author | Acosta, M. Barreiro-de | |
dc.contributor.author | Savarino, E. V. | |
dc.contributor.author | Gisbert, J. P. | |
dc.contributor.author | Vecchi, M. | |
dc.contributor.author | Atreya, R. | |
dc.contributor.author | Caprioli, F. | |
dc.date.accessioned | 2025-03-07T13:32:47Z | |
dc.date.available | 2025-03-07T13:32:47Z | |
dc.date.issued | 2025-01 | |
dc.description.abstract | Inflammatory bowel disease (IBD) patients with Clostridiodes difficile Infection (CDI) are at increased risk of disease exacerbations, therapy escalation, colectomy, and mortality. Data on fidaxomicin use in IBD patients with CDI are very limited. We aimed to assess the effectiveness and safety of fidaxomicin for CDI and its impact on IBD outcomes in a large retrospective multicenter cohort study | eng |
dc.identifier.doi | 10.1093/ecco-jcc/jjae190.1330 | |
dc.identifier.issn | 1873-9946 | |
dc.identifier.issn | 1876-4479 | |
dc.identifier.uri | http://hdl.handle.net/10400.1/26878 | |
dc.language.iso | eng | |
dc.peerreviewed | yes | |
dc.publisher | Oxford University Press | |
dc.relation.hasversion | https://academic.oup.com/ecco-jcc/article/19/Supplement_1/i2110/7972008 | |
dc.relation.ispartof | Journal of Crohn's and Colitis | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.title | Fidaxomicin for Clostridiodes difficile infection in inflammatory bowel disease: a multicenter retrospective cohort study | eng |
dc.type | conference object | |
dspace.entity.type | Publication | |
oaire.citation.endPage | I2112 | |
oaire.citation.issue | Supplement_1 | |
oaire.citation.startPage | I2110 | |
oaire.citation.title | Journal of Crohn's and Colitis | |
oaire.citation.volume | 19 | |
oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Fidaxomicin for Clostridiodes difficile infection in inflammatory bowel disease.pdf
- Size:
- 2.25 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 3.46 KB
- Format:
- Item-specific license agreed upon to submission
- Description: